First Turn Management’s Xenon Pharmaceuticals XENE Stock Holding History

First Turn Management’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$45.8M	Sell	786,844 -12,899	-2%	-$594K	5.11%	4
2025 Q4	$35.8M	Hold	799,743	–	–	4.1%	8
2025 Q3	$32.1M	Buy	799,743 +139,126	+21%	+$4.9M	4.82%	6
2025 Q2	$20.7M	Sell	660,617 -22,834	-3%	-$745K	3.86%	8
2025 Q1	$22.9M	Sell	683,451 -1,535	-0.2%	-$58.3K	4.62%	5
2024 Q4	$26.9M	Buy	684,986 +359,768	+111%	+$14.9M	4.81%	3
2024 Q3	$12.8M	Sell	325,218 -14,658	-4%	-$591K	2.03%	30
2024 Q2	$13.3M	Sell	339,876 -340,513	-50%	-$13.6M	2.16%	23
2024 Q1	$29.3M	Hold	680,389	–	–	4.38%	4
2023 Q4	$31.3M	Buy	+680,389	New	+$24M	4.5%	5

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Turn Management's XENE Position: Q1 2026 in Review

First Turn Management reduced its Xenon Pharmaceuticals (XENE) stake by 1.6% in Q1 2026, selling an estimated $594K and leaving 786,844 shares worth $45.8M. The position accounts for 5.11% of the portfolio, ranked #4.

First Turn Management first reported a position in XENE in Q4 2023 and has held it in 10 quarters since. 290 funds tracked by Wall St. Rank hold XENE as of Q1 2026.

First Turn Management held 786,844 shares of Xenon Pharmaceuticals worth $45.8M as of Q1 2026.
First Turn Management sold 12,899 Xenon Pharmaceuticals shares in Q1 2026, an estimated $594K.
Xenon Pharmaceuticals made up 5.11% of First Turn Management's portfolio in Q1 2026, its #4 holding.
First Turn Management first reported a position in Xenon Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
290 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2026.

Based on First Turn Management's 13F filing for Q1 2026, filed 15 May 2026.